Portage Biotech Inc
PRTG
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.52M
Close$
$0.24
96.4% downside
Current Fair Value
96.4% downsideOvervalued by 96.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $15.52 Million |
|---|---|
| Enterprise Value | $13.85 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.72 |
| Beta | 0.64 |
| Outstanding Shares | 1,303,000 |
Return
| Return on Equity | 5501.63% |
|---|---|
| Return on Assets | -304.13% |
| Return on Invested Capital | -659.38% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.03 |
| Price to Sales | - |
| Price to Book Ratio | -6.81 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.87 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
February 26, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Portage Biotech Inc
Portage Biotech Inc. is a unique entity in the world of biotechnology, catalyzing R&D to produce more quality clinical programs and maximize potential returns.